Accueil Ernstrade Bourse Actualite Stock

plus500
Germany

The Group's principal activities are discovering and developing of new drugs. The Group operates through two segments: Discovery and development services and Discovery Programs Division. The Group's discovery and development services segment provides screening, assay development, chemical compound optimisation and production and disease targets. The discovery programs division focuses on internal discovery programs. The Group operates in Europe, USA and Rest of the World.

http://www.evotec.com

Copyright  22010 Ernstrade.com